Cytokine release syndrome

During the last decade the field of cancer immunotherapy has witnessed impressive progress. Highly effective immunotherapies such as immune checkpoint inhibition, and T-cell engaging therapies like bispecific T-cell engaging (BiTE) single-chain antibody constructs and chimeric antigen receptor (CAR)...

Descripción completa

Detalles Bibliográficos
Autores principales: Shimabukuro-Vornhagen, Alexander, Gödel, Philipp, Subklewe, Marion, Stemmler, Hans Joachim, Schlößer, Hans Anton, Schlaak, Max, Kochanek, Matthias, Böll, Boris, von Bergwelt-Baildon, Michael S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6003181/
https://www.ncbi.nlm.nih.gov/pubmed/29907163
http://dx.doi.org/10.1186/s40425-018-0343-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6003181/
https://www.ncbi.nlm.nih.gov/pubmed/29907163
http://dx.doi.org/10.1186/s40425-018-0343-9

Ejemplares similares